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Background: The study investigates the prevalence of Panic Disorder (PD) with or without comorbid
Major (MD) or Minor Depressive (md) disorder during pregnancy and focuses its attention on the
different pattern of risk factors in these two subgroups in a sample of women attending two Centres for
Prenatal Care of the Public Health Service.
Methods: Two-hundred and seventy-seven pregnant women were assessed monthly throughout the
whole pregnancy period using the Primary Care Evaluation of Mental Disorders (PRIME-MD) for the
screening of PD and the Hospital Anxiety and Depression Scale (HADS) for the evaluation of severity of
anxious and depressive symptoms.
Results: Twenty-one women (7.5%) were diagnosed as affected by PD, of whom 12 (57.1%) showed MD
or md comorbidity. The development of PD without depressive comorbidity is predicted by a history of
previous episodes of Anxiety Disorders while the development of PD plus depressive comorbidity is
predicted by a history of previous depressive episodes and by the lack of familiar support.
Limitations: Given the small sample size of our anxious and depressed women, the present data need to
be veriﬁed by using larger samples.
Conclusions: The frequent association between PD and MD or md, the analysis of risk factors and of
temporal relationship strongly suggests that the panic-depressive comorbidity might represent in
fact depressive disorders with intense anxiety symptoms. These ﬁndings raise the question if the
PD-depressive association is a true comorbidity or reveals the anxious symptomatology of a depressive
disorder (MD or md).
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
There is a consistent body of clinical research focusing on
depression during the perinatal period, pregnancy and the ﬁrst
year postpartum, whereas anxiety disorders in these same periods
have received less research attention. It was previously thought
that pregnancy was a time of low risk for the new onset or
exacerbation of an anxiety disorder. However, there is growing
realization that symptoms of anxiety are common during preg-
nancy and postpartum and maternal symptoms of anxiety during
pregnancy are associated with adverse fetal and developmental
consequences.
Panic Disorder (PD) is one of the most prevalent and disabling
anxiety disorders. According to the Epidemiological Catchment's
Area population survey (Regier et al., 1990), lifetime prevalence for
PD is estimated at 2.2%, and women are 2.5–3 times more likely
than men to meet criteria for PD (3.4% vs. 0.9%). The Epidemiolo-
gical Catchment's Area data also demonstrated an increased risk
for PD in those under age 45 years (Regier et al., 1990). Interna-
tional reports conﬁrm that women have signiﬁcantly higher
prevalence rates of PD (Kessler et al., 1994; Alonso et al., 2004).
It has been estimated that 3–12% of women experience symp-
toms related to PD at some time during their childbearing years,
including pregnancy and the postpartum period (Wenzel et al.,
2001; Smith et al., 2004; Andersson et al., 2006; Goodman and
Tyer-Viola, 2010), and according to available data 3–11% of women
with PD report the onset during perinatal period (Ross and McLean,
2006). PD is not only common but is also considered to be a chronic
and debilitating illness associated with signiﬁcant comorbidity
(Ballenger et al., 1998; Yonkers et al., 1998). Noteworthy, approxi-
mately 50% of individuals with PD also have comorbid Major
Depression (MD). Furthermore, several prospective studies have
shown that a prenatal anxiety disorder is one of the strongest risk
factors for developing postnatal depression (Andersson et al., 2003;
Sutter-Dallay et al., 2004; Milgrom et al., 2008). Therefore, an
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anxiety disorder in pregnancy may be associated with signiﬁcant
maternal depressive morbidity.
Despite these important clues, there is lack of literature
reporting risk factors for or predictors of antenatal PD and patterns
of depressive comorbidity.
Therefore, the present study was aimed to investigate the
prevalence of PD with or without comorbid depression at several
times during pregnancy and to evaluate the pattern of risk factors
in these two subgroups in a Italian sample of women attending
two Centres for Prenatal Care of the Public Health Service.
2. Methods
Both the Local Ethical Committee (Comitato Unico della Pro-
vincia di Mantova e della Provincia di Reggio Emilia) approved the
study protocol.
2.1. Sample
The study population was recruited among women who con-
secutively sought assistance at the Centres for Prenatal Care of the
Public Health Service of District of Mantova (Italy) and Reggio
Emilia (Italy), from September 2005.
Women participated in the study after the procedure had been
fully explained and a written informed consent was obtained, if
they were older than 18 years and completed all the evaluations
from the beginning of their pregnancy.
2.2. Assessment
At each visit, all women were asked to complete (approxi-
mately every month) the following evaluations: (1) the Italian
translation of the Primary Care Evaluation of Mental Disorders
(PRIME-MD) (Spitzer et al., 1994) for the screening of PD; (2) the
Italian translation of the Hospital Anxiety and Depression Scale
(HADS) (Zigmond and Snaith, 1983) for the evaluation of severity
of anxious and depressive symptoms.
Moreover, all women completed a brief questionnaire, per-
formed ad hoc, to collect socio-demographic and medical history
information, and to evaluate the presence (or absence) of pro-
blems with husband/partner, family, job, family support and
whether the pregnancy was unwanted. The results of the ques-
tionnaire were discussed with the women (and when available
with family members) to conﬁrm their answers.
The PRIME-D is a structured interview for the diagnosis of
mental disorders according to the criteria of DSM-IV (American
Psychiatric Association, 1994). It has not been validated for the use
in a pregnant population, however it showed good speciﬁcity and
sensitivity in detecting PD (speciﬁcity 99%, sensitivity 57%) and
MD (speciﬁcity 98%, sensitivity 57%) in primary care populations
(Spitzer et al., 1994).
The interview was administered at each visit by the gynecol-
ogists, who were trained by a senior psychiatrist.
A woman was affected by PD if, at any evaluation during
pregnancy, she fulﬁlled the criteria for a PD episode. A woman was
deﬁned non-anxious if she did not satisfy the criteria for PD or anxiety
disorder not otherwise speciﬁed at any evaluation during pregnancy.
The duration and onset of PD (the month in which anxious
symptoms ﬁrstly satisﬁed the diagnostic criteria for PD) through-
out pregnancy were calculated. In women, who showed anxious
symptoms at the ﬁrst evaluation, the onset was arbitrarily con-
sidered the ﬁrst month of pregnancy.
Concerning treatment of PD, only women with severe anxious
symptoms (on clinical judgment) were referred by gynecologist to
psychiatrist for a treatment. The gynecologists were properly
trained to recognize this severe condition.
2.3. Statistical analysis
Comparisons between PD and non-anxious women were per-
formed using the one-way analysis of variance with Bonferroni
post-hoc analysis for continuous variables and with Fisher's exact
test for categorical variables.
Stepwise logistic regression was used to evaluate which vari-
ables at the beginning of pregnancy could predict the develop-
ment of depression. Two regression analysis were performed: the
same independent variables entered in both analyses were occu-
pation, number of childbirths, presence of problems with hus-
band/partner, family, job, presence of family support and whether
the pregnancy was unwanted, whereas the dependent variables
were MD and no depression in one analysis and md and no
depression in the other analysis.
3. Results
3.1. Sample
During the study period, 356 women attended the Centres of
Prenatal Care. Thirty-two women (8.9%) were not included in the
study because of language problems (n¼17) or refusal to partici-
pate (n¼15). Among the remaining 324 women, 25 (7.7%) were
excluded from the study because they did not attend all the visits
throughout pregnancy. Among non-completers, 15 dropped-out
after the ﬁrst evaluation, 7 attended another visit and 3 two more
visits. At the beginning of pregnancy, the 25 non-completers
showed the same socio-demographic features of the completers.
Moreover, none of the non-completers showed anxious or depres-
sive symptoms at any evaluation they attended.
Among the remaining 299 women, 22 women were excluded
from the study because they presented during pregnancy anxious
symptoms, which did not satisfy the diagnostic criteria of PD
(anxiety disorder not otherwise speciﬁed). However, women with
anxiety disorder not otherwise speciﬁed were considered when
the prevalence of PD was calculated.
Therefore the study population included 277 women (mean
age 30.774.4 years; range 18–45 years. Twenty-one women were
diagnosed as affected by PD and the remaining 256 did not present
anxious symptoms during pregnancy (healthy controls) (C). PD
and C women showed the same age, years of education and family
or occupational status, whereas PD women had higher number of
childbirths, more frequently reported an absence of family support
and depressive or anxious episode before pregnancy (Table 1).
Moreover, PD and C women showed the same number of assess-
ments (PD¼6.171.3 vs. C¼6.071.3; t¼0.43; p¼0.66).
In anxious women, the PD symptoms became evident after
4.072.1 months of pregnancy and they lasted 3.072.0 months
(Table 2).
3.2. Depressive comorbidity
PD women showed more depressive episodes during preg-
nancy that C (Table 1). Twelve PD women (57.1%) presented
depressive episode during pregnancy: MD was diagnosed in
5 anxious women and md in 7. In seven women, PD was
concomitant with MD (n¼3) or md (n¼4) whereas in 5 women
PD preceded MD (n¼2) or md (n¼3).
Concerning treatments, no anxious or depressed women were
treated with antidepressants or other psychotropic drugs. Only
two women with MD received a psychological support.
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3.3. Predictive risk of developing PD
At the beginning of pregnancy when PD women were com-
pared with non-anxious women using the stepwise logistic
regression, the risk factors for developing PD were different for
PD without depression and for PD with depressive comorbidity.
The development of PD without depressive comorbidity was
predicted by the presence of previous anxious episode (χ2¼11.4;
p¼0.001; OR¼15.9; CI 95%¼3.2–79.4), whereas number of child-
births, unwanted pregnancy, conﬂict with the husband/partner,
problems with the family or the job, family support and previous
depressive episodes did not show any effect (Table 3).
The development of PD with depressive comorbidity was pre-
dicted by the presence of previous depressive episode (χ2¼14.1;
po0.0011; OR¼10.1; CI 95%¼3.0–33.9) and by the absence of family
support (χ2¼4.7; p¼0.03; OR¼4.2; IC 95%¼1.1–15.5), whereas
number of childbirths, unwanted pregnancy, conﬂict with the hus-
band/partner, problems with the family or the job, and previous
anxious episodes did not show any effect (Table 3).
4. Discussion
To our knowledge, this is the ﬁrst prospective study investigat-
ing the presence of PD nearly at monthly intervals throughout
pregnancy. The frequent assessment of PD (6.171.3 times) gave
the possibility to evaluate the duration of the anxious episode and
its relationship with MD or md. In our sample, 21 women (7.0%)
were diagnosed as affected by PD, of whom 12 showed MD or md
comorbidity. It is difﬁcult to compare our result to other studies
focusing on the prevalence of PD during pregnancy because they
are few and there are deep methodological differences between
them (Ross and McLean, 2006; Guler et al., 2008). Previous studies
focused on point prevalence at a speciﬁc period during pregnancy
(2nd trimester, 3rd trimester), our research otherwise point at a
prevalence throughout all the duration of pregnancy. Moreover
there are methodological discrepancies concerning the diagnostic
methodology (different self-report measures, clinical interviews)
(Guler et al., 2008). However our prevalence rates is in line with
the data from the literature which report that 3% to 12% of women
experience symptoms related to PD at some time during their
childbearing years, including pregnancy and the postpartum
period (Wenzel et al., 2001; Smith et al., 2004; Andersson et al.,
2006; Goodman and Tyer-Viola, 2010;), and according to available
data, 3–11% of women with PD report the onset during perinatal
period (Ross and McLean, 2006).
Concerning the socio-demographic characteristics, PD women
compared with controls, showed lower level of education, higher
number of childbirths and a lower family support. However, only
the lack of family support represented a risk factor for developing
PD during pregnancy in multivariate analysis (see below).
Moreover, PD women, compared to controls, showed signiﬁ-
cant higher rates of depressive comorbidity, both MD and md, and
they had more frequently anxious or depressive episodes before
pregnancy.
The high prevalence of depressive comorbidity (57%) in preg-
nant women with PD conﬁrms the data from the literature
(Kaufman and Charney, 2000), which reports that MD occurs in
patients with PD in 56–73% of cases. We do not acknowledge
previous studies exploring prevalence of PD-depression comor-
bidity during pregnancy.
While analyzing the rate of PD among the three trimester of
pregnancy we found that women with pure PD showed the typical
Table 1
Socio-demographic and clinical features in women who developed major depres-
sion or. minor depression during pregnancy and in healthy pregnant women
Panic
Disorder
(n¼21)
No anxiety
(n¼256)
Age (years) 31.973.9 30.774.4 t¼1.2 p¼0.23
Education (years) 11.073.1 12.373.3 t¼1.7 p¼0.08
Family status χ2¼4.7 p¼0.58
Never married 2 (9.5%) 41 (16.0%)
Married 18 (85.7%) 186 (72.7%)
Living together 1 (4.8%) 27 (10.5%)
Separated/Divorced – 2 (0.8%)
Occupation χ2¼4.3 p¼0.21
Unemployed 0 1 (0.8%)
Student 0 2 (1.7%)
Housewife 6 (37.5%) 8 (7.1%)
Employed 10 (62.5%) 101 (90.1%)
Depression during
pregnancy
χ2¼18.1 p¼0.001
No depression 9 (42.8%) 214 (83.6%)
Major depression 5 (23.8%) 13 (5.1%)
Minor depression 7 (33.3%) 29 (11.3%)
Number of children 0.9070.83 0.5470.63 t¼2.4 p¼0.01
Problems with
husband/partner
Yes 1 (4.8%) 6 (2.3%) χ2¼0.4 p¼0.42
Problems with
family
Yes 2 (9.5%) 5 (2.0%) χ2¼4.5 p¼0.09
Problems with job Yes 3 (14.3%) 29 (11.3%) χ2¼0.1 p¼0.72
Family support No 11 (52.4%) 60 (23.4%) χ2¼8.5 p¼0.006
Unwanted
pregnancy
Yes 5 (23.8%) 83 (32.4%) χ2¼0.6 p¼0.47
Previous anxiety
episodes
Yes 14 (66.7%) 46 (18.0%) χ2¼27.1 po0.001
Previous depressive
episodes
Yes 12 (57.1%) 31 (12.1%) χ2¼30.0 po0.001
Table 2
Onset and duration of PD in women with or without depressive disorder (both MD
and md)
Panic Disorder
With D (n¼12) Without D (n¼9)
Onset
Trimester 1st 4 33.3% 4 44.4%
Trimester 2nd 7 58.3% 1 11.1%
Trimester 3rd 1 8.3% 4 44.4%
Duration months 3.270.9 2.771.6
Onset χ2¼5.9; df¼1; p¼0.05.
Duration t¼0.8; df¼19; p¼0.42.
Table 3
Risk factors for developing Panic Disorder (PD) with or without depression in
pregnant women.
Presence of PD in pregnant women
β χ2 Wald p OR CI 95% R2
PD without depression
Previous anxious episodes 2.7 11.4 0.001 15.9 3.2–79.4 0.21
PD with depression
Step 1 0.16
Previous depressive episodes 2.3 14.1 o0.001 10.1 3.0–33.9
Step 2 0.22
Family support (no) 1.4 4.7 0.03 4.2 1.1–15.5
Previous depressive episodes 1.9 9.1 0.002 6.9 1.9–24.6
The independent variables entered in each logistic regression were: age, number of
sons, unwanted pregnancy, family support, problems with husband/partner,
problems with family, problems with job, previous anxious or depressive episodes.
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"U-shaped" pattern (Figueiredo and Conde, 2011), also observed in
GAD population during pregnancy (Buist et al., 2011), with
incidence decreasing from the 1st to the 2nd trimester and then
increasing from the 2nd trimester with the proximity of childbirth.
Women with PD and comorbid depression showed a “reverse
U-shaped” pattern, with an increase of incidence from 1st to 2nd
trimester and a dramatic fall of the incidence in the 3rd trimester.
To our knowledge no studies reported the incidence of PD
comorbid with mood disorders among the three trimester of
pregnancy. Many authors who studied the timing of MD during
pregnancy reported a decrease in depression from the 1st to the
3rd pregnancy trimester (Figueiredo and Conde, 2011).
Some authors (Figueiredo and Conde, 2011) suggest that the
increase in anxiety symptoms from the 2nd to 3rd pregnancy
trimester may be related with the proximity of childbirth and the
decrease in depression symptoms from the 2nd to the 3rd
pregnancy trimester with the emergent presence of the newborn
in the parent's life. However, it might also be supposed that the
U-shaped pattern of the frequency of PD during pregnancy reﬂect
the effect of the stressor that exerts its highest effect in the
beginning of its action (1st trimester) and in proximity to the
end (3rd trimester) when the difﬁculties in the management of the
new life event are higher. Otherwise, biological adjustments can
also be related with these psychological changes.
In this study we found different patterns of risk factors when
comparing women who developed PD during pregnancy with and
without depressive disorder.
The development of PD without depressive comorbidity is pre-
dicted by a history of previous anxious episodes while the develop-
ment of PD plus depressive comorbidity is predicted by a history of
previous depressive episodes and by the lack of familiar support.
This ﬁnding is in line with previous worldwide researches
stating that the most consistent risk factors of depressive disorder
during pregnancy and post partum are a problematic familiar
relationships and previous depressive episodes (Dietz et al., 2007;
Marchesi et al., 2009; Lancaster et al., 2010), suggesting that
pregnant women with comorbid PD and depression share the
common risk factors of depressive states.
This ﬁnding raises the question if the pattern of PD-depressive
comorbidity found in our study represents true comorbidity
between two distinct disorders (PD and MD or md) or otherwise
reveals the anxious symptomatology of a depressive disorder (MD
or md). A closer look to the temporal relationship between PD and
depressive disorders shows that in 11 of 12 gestants (91.7%) the
two comorbid entities coexist (synchronic or intra-episodic
comorbidity) and in one sole case the two disorder appear
temporally unrelated. Analyzing the data of intra-episodic comor-
bidity, in ﬁve pregnant women (45.4%) the two disorders show a
common onset, in four cases (36.4%) the onset of PD precedes the
onset of depressive disorder. Only in two cases (18.2%) the onset of
depression precedes the onset of PD. Taken together, the data of
risk factors and of temporal relationship strongly suggests that
maybe the panic-depressive comorbidity observed in this study
represents in fact depressive disorders with intense anxiety
symptoms. However, we cannot exclude that this comorbidity
might be an artifact due to the limitations of the diagnostic
instrument (the PRIME-MD interview) and its inability to detect
true panic-depression comorbidity.
To our knowledge no studies explored the predictors of PD in
perinatal period; one study found that Generalized Anxiety Dis-
order (GAD) during pregnancy is predicted by previous GAD
episodes (Buist et al., 2011). These two ﬁndings taken together
suggest that anxiety symptoms are predicted by previous anxious
episodes.
This study conﬁrms that PD is a common and troublesome
condition during pregnancy and postpartum and may have severe
consequences on mother mental health as well as depressive
disorders. Moreover, in almost a half of the cases the two
conditions may frequently coexist, in the mean time or at different
intervals, in the same subjects. Our study raises the question that
often panic, at least as measured by PRIME-MD, might be a
prodromal or an anxious manifestation of a depressive disorder
(MD or md). It is therefore strongly recommended an effort to
screen and precociously intervent on these pathological condi-
tions. A complete social and medical history combined with the
knowledge of potential risk factors may contribute to perceive
these goals and prevent further complications both on the mother
and on the child. It is worth to note that the presence of anxiety
disorder during pregnancy (Andersson et al., 2003; Robertson
et al., 2004; Sutter-Dallay et al., 2004; Milgrom et al., 2008) and
particularly in the 3rd trimester has been associated with a high
risk (RR 9.5) of post-partum depression (Oppo et al., 2009).
Some methodological aspects limit the generalization of our
results.
The ﬁrst main limitation of this investigation is the small size of
the overall sample of patients with PD and the utterly small size of
the subgroups showing depressive comorbidity. This cannot allow
us to make any ﬁrm conclusion, however it might represent an
interesting observation that should be veriﬁed in larger samples.
Second, a psychiatrist did not diagnose PD, MD or md and
therefore our data might be poorly reliable. However, the anxious
and depressive episodes were diagnosed using the PRIME-MD, an
interview performed to evaluate mental disorders in primary care,
which showed a good reliability between diagnoses obtained by
trained physicians and those obtained by psychiatrist (Spitzer
et al., 1994). Moreover, the PRIME-MD, although not validated in
pregnant populations, as stated before, showed good speciﬁcity
and sensitivity in detecting both PD and MD in primary care
(Spitzer et al., 1994).
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